Investors Sue APLT After FDA Issues Warning Letter

Applied Therapeutics is under fire after the FDA issued the pharmaceutical company a warning letter for submitting problematic data. Shocked investors rapidly dumped their shares, causing the Company's stock price to plummet. Some of those investors are now suing the Company to recoup their losses.

Applied Therapeutics was investigating govorestat, a drug to treat a glucose disorder. The Company's executives made glowing remarks about the likelihood of FDA and European approval.

But, those executives should have known better.

Investors learned the truth in November 2024 when the FDA issued a Complete Response Letter knocking back the drug citing "deficiencies in the application." Then, a few days later, the FDA sent Applied Therapeutics a stern warning letter, revealing inconsistencies in the study's data.

Investors and analysts were stunned by the revelation, causing the stock's price to freefall. Now, some of those investors are joining the lawsuit.

Join the Lawsuit.